Spain fines pharmaceuticals cartel €5.8 million

Spain's antitrust enforcer has fined the country's only two suppliers of drugs used in nuclear medicine – including a local Novartis subsidiary – for dividing the market and rigging tenders.


Get unlimited access to all Global Competition Review content